FDA Drug Recalls

6,161 recalls · Class II, newest first

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 5% Dextrose Injection

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-310-41 D-0995-2017

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 0.9% Sodium Chloride Injection

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-286-48 D-0994-2017

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 5% Dextrose Injection

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-299-48 D-0993-2017

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 0.9% Sodium Chloride Injection

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-298-48 D-0992-2017

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 0.9% Sodium Chloride Injection

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-284-48 D-0991-2017

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 0.9% Sodium Chloride Injection

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-301-11 D-0990-2017

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 5% Dextrose Injection

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-283-03 D-0989-2017

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 0.9% Sodium Chloride Injection 20 mMol in…

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-287-48 D-0988-2017

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 0.9% Sodium Chloride Injection 15 mMol in…

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-295-48 D-0987-2017

Jun 26, 2017 Class II · Moderate risk

Potassium PHOSphate in 0.9% Sodium Chloride Injection

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-288-48 D-0986-2017

Jun 26, 2017 Class II · Moderate risk

Succinylcholine Chloride Injection

Lack of Assurance of Sterility; media fill failure at manufacturer

Terminated Sterility / contamination PharMedium Services, Llc NDC 61553-364-65 D-0985-2017

Jun 22, 2017 Class II · Moderate risk

Potassium Phosphate

Lack of Assurance of Sterility

Terminated Sterility / contamination Advanced Pharma Inc. NDC 15082-922-25 D-0956-2017

Jun 22, 2017 Class II · Moderate risk

Potassium Phosphate

Lack of Assurance of Sterility

Terminated Sterility / contamination Advanced Pharma Inc. NDC 15082-924-25 D-0955-2017

Jun 22, 2017 Class II · Moderate risk

Potassium Phosphate

Lack of Assurance of Sterility

Terminated Sterility / contamination Advanced Pharma Inc. NDC 15082-926-25 D-0954-2017

Jun 22, 2017 Class II · Moderate risk

QUELICIN (Succinylcholine Chloride)

Lack of Assurance of Sterility

Terminated Sterility / contamination Advanced Pharma Inc. NDC 15082-814-67 D-0953-2017

Jun 21, 2017 Class II · Moderate risk

Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMol

Lack of sterility assurance

Terminated Sterility / contamination SCA Pharmaceuticals NDC 70004-0843-40 D-0979-2017

Jun 21, 2017 Class II · Moderate risk

Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol

Lack of sterility assurance

Terminated Sterility / contamination SCA Pharmaceuticals NDC 70004-0841-32 D-0978-2017

Jun 21, 2017 Class II · Moderate risk

Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol

Lack of sterility assurance

Terminated Sterility / contamination SCA Pharmaceuticals NDC 70004-0841-40 D-0977-2017

Jun 21, 2017 Class II · Moderate risk

Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 10 mMol

Lack of sterility assurance

Terminated Sterility / contamination SCA Pharmaceuticals NDC 70004-0840-40 D-0976-2017

Jun 19, 2017 Class II · Moderate risk

Succinylcholine Chloride

Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier

Terminated Sterility / contamination Fagron Compounding Services LLC dba Fagron Sterile Services D-0946-2017

Jun 16, 2017 Class II · Moderate risk

Clindamycin Injection USP

Lack of Assurance of Sterility

Terminated Sterility / contamination Alvogen, Inc NDC 47781-464-69 D-0941-2017

Jun 16, 2017 Class II · Moderate risk

Clindamycin Injection USP

Lack of Assurance of Sterility

Terminated Sterility / contamination Alvogen, Inc NDC 47781-463-69 D-0940-2017

Jun 16, 2017 Class II · Moderate risk

Clindamycin Injection USP

Lack of Assurance of Sterility

Terminated Sterility / contamination Alvogen, Inc NDC 47781-462-69 D-0939-2017

Jun 15, 2017 Class II · Moderate risk

Neut Sodium Bicarbonate 4%

Lack of Sterility Assurance

Terminated Sterility / contamination Hospira a Pfizer Company NDC 0409-6609-02 D-1049-2017

Jun 15, 2017 Class II · Moderate risk

Succinylcholine Chloride Injection

Lack of Sterility Assurance

Terminated Sterility / contamination Hospira a Pfizer Company D-1048-2017

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061